Taste and Smell Impairment in Critically Ill COVID-19 Patients

Coronavirus Infection Clinical Trial

Official title:

Taste and Smell Impairment in Critically Ill COVID-19 Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04532632
• Other study ID #: 3334-02
• Status: Completed
• Start date: September 1, 2020
• Est. completion date: October 9, 2020

Study information

• Verified date: November 2020
• Source: Sisli Hamidiye Etfal Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Evaluating the smell and taste perceptions of patients hospitalized in the intensive care unit with suspicion of Coronavirus disease-19 diagnosis with a survey study

Description:

Patients who were treated in the intensive care unit of Şişli Hamidiye Etfal Training and Research Hospital with the diagnosis of Coronavirus disease-19 will be determined by scanning the hospital registry system. It was planned that patients discharged from the intensive care unit would be called by phone and their complaints about smell and taste disorders were evaluated with a questionnaire.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: October 9, 2020
• Est. primary completion date: October 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Adults between the ages of 18-80

• Agree to participate in the study

• Patients treated in the intensive care unit with the diagnosis of Coronavirus disease-19

Exclusion Criteria:

• Pre-existing smell and taste impairment

• The patients have no enough cooperation to answer the questionnaire

• Having additional diseases such as dementia and Alzheimer

Related Conditions & MeSH terms

• Coronavirus Infection
• Coronavirus Infections
• Disease
• Olfaction Disorders
• Severe Acute Respiratory Syndrome
• Smell Disorder
• Taste Disorders

Locations

Country	Name	City	State
Turkey	Sisli Etfal Research and Training Hospital	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Pinar Ay Sayin

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg. 2020 May 4;49(1):26. doi: 10.1186/s40463-020-00423-8. — View Citation

Sayin I, Yasar KK, Yazici ZM. Taste and Smell Impairment in COVID-19: An AAO-HNS Anosmia Reporting Tool-Based Comparative Study. Otolaryngol Head Neck Surg. 2020 Sep;163(3):473-479. doi: 10.1177/0194599820931820. Epub 2020 Jun 9. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	taste and smell impairment	incidence of taste and smell impairment in critically ill subjects	up to 3 months